A multi-centre, phase II - III randomised clinical trial and observational study of defibrotide for the treatment of hepatic veno-occlusive disease after stem cell transplant
Completed
- Conditions
- Hepatic veno-occlusive disease (VOD)Digestive SystemOther diseases of liver
- Registration Number
- ISRCTN65464501
- Lead Sponsor
- Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients with diagnosis of VOD after a stem cell transplant.
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival at 7, 14, 30, 60 and 100 days after diagnosis.
- Secondary Outcome Measures
Name Time Method ot provided at time of registration